ProQR Therapeutics (@proqr) 's Twitter Profile
ProQR Therapeutics

@proqr

Developing medicines using our proprietary Axiomer RNA-editing technology platform
$PRQR #RNA #biotech #Axiomer #RNAediting

ID: 498346137

linkhttp://www.proqr.com calendar_today20-02-2012 23:24:50

875 Tweet

1,1K Followers

87 Following

ProQR Therapeutics (@proqr) 's Twitter Profile Photo

On a recent Saturday, ProQRians and their families gathered for lab tours, science scavenger hunts, and more fun as part of "ProQR Family Day". A big thanks to all who helped make the day so special. Here’s to more moments of connection and celebration! ❤️

On a recent Saturday, ProQRians and their families gathered for lab tours, science scavenger hunts, and more fun as part of "ProQR Family Day". A big thanks to all who helped make the day so special. Here’s to more moments of connection and celebration! ❤️
ProQR Therapeutics (@proqr) 's Twitter Profile Photo

A big thanks to our Scientific Advisory Board and Board Members for joining our recent Axiomer Summit! This internal event was packed with insightful presentations, vibrant scientific discussions, and an exciting poster session. #RNAediting #AxiomerSummit

A big thanks to our Scientific Advisory Board and Board Members for joining our recent Axiomer Summit! This internal event was packed with insightful presentations, vibrant scientific discussions, and an exciting poster session. #RNAediting #AxiomerSummit
ProQR Therapeutics (@proqr) 's Twitter Profile Photo

ProQR is hosting a Virtual Analyst & Investor Event on Dec 11 at 10 am EST. Learn about the latest in our Axiomer RNA editing platform and pipeline. For more info and to register: proqr.com/events #RNAEditing #Axiomer #Biotech $PRQR

ProQR Therapeutics (@proqr) 's Twitter Profile Photo

Today we are pleased to announce Dr. Peter Beal as our Chief ADAR Scientist. Read more: proqr.com/press-releases… #RNAEditing #Axiomer

Today we are pleased to announce Dr. Peter Beal as our Chief ADAR Scientist. Read more:
proqr.com/press-releases…

#RNAEditing #Axiomer
ProQR Therapeutics (@proqr) 's Twitter Profile Photo

ProQR and Rett Syndrome Research Trust expand partnership with $8.1 M from RSRT to advance Axiomer for Rett Syndrome. Read more: bit.ly/3BqO46f #RNAEditing #Axiomer #RettSyndrome $PRQR

ProQR Therapeutics (@proqr) 's Twitter Profile Photo

Event reminder – ProQR’s Virtual Investor & Analyst Event starts in ~1 hour (10 am EST, Dec 11). Join at: proqr.com/events/2024-12… #RNAEditing $PRQR

Event reminder – ProQR’s Virtual Investor & Analyst Event starts in ~1 hour (10 am EST, Dec 11). Join at: proqr.com/events/2024-12…
#RNAEditing $PRQR
ProQR Therapeutics (@proqr) 's Twitter Profile Photo

Today marks the 10th anniversary of International Day of Women and Girls in Science. At ProQR, we are proud to celebrate our brilliant #WomeninScience, as they share their insights and reflect on their scientific journeys. #RNAediting #Axiomer #WomeninSTEM

Today marks the 10th anniversary of International Day of Women and Girls in Science. At ProQR, we are proud to celebrate our brilliant #WomeninScience, as they share their insights and reflect on their scientific journeys.

#RNAediting #Axiomer #WomeninSTEM
ProQR Therapeutics (@proqr) 's Twitter Profile Photo

Coffee, connections, and celebrating women’s achievements! This week, our team came together for #IWD2025 at our monthly coffee & collaboration event. Learn more about life at ProQR: proqr.com/careers #InternationalWomensDay #Axiomer #RNAediting

Coffee, connections, and celebrating women’s achievements! This week, our team came together for #IWD2025 at our monthly coffee & collaboration event.

Learn more about life at ProQR: proqr.com/careers

#InternationalWomensDay #Axiomer #RNAediting
ProQR Therapeutics (@proqr) 's Twitter Profile Photo

Today we announced our results for the year ended December 31, 2024 and shared a business update. Read the full press release here: bit.ly/3R6xDjz $PRQR #biotech #Axiomer #RNAediting

Today we announced our results for the year ended December 31, 2024 and shared a business update. Read the full press release here: bit.ly/3R6xDjz
$PRQR #biotech #Axiomer #RNAediting
ProQR Therapeutics (@proqr) 's Twitter Profile Photo

This week, CSO Gerard Platenburg and Chief ADAR Scientist Peter Beal joined the #RNAEditing Gordon Research Conference in Lucca, Italy. Gerard presented on advancing #Axiomer RNA editing for liver and CNS applications. Find the pres here: proqr.com/presentations-…

This week, CSO Gerard Platenburg and Chief ADAR Scientist Peter Beal joined the #RNAEditing Gordon Research Conference in Lucca, Italy. Gerard presented on advancing #Axiomer RNA editing for liver and CNS applications. Find the pres here: proqr.com/presentations-…
ProQR Therapeutics (@proqr) 's Twitter Profile Photo

We’re excited to welcome Dennis Hom as CFO and Dr. Cristina Lopez Lopez as CMO to drive the next phase of growth. Their leadership comes at a pivotal time as we prepare to advance our Axiomer™ RNA editing platform into the clinic. bit.ly/4ja0IY0 #RNAediting #leadership

We’re excited to welcome Dennis Hom as CFO and Dr. Cristina Lopez Lopez as CMO to drive the next phase of growth. Their leadership comes at a pivotal time as we prepare to advance our Axiomer™ RNA editing platform into the clinic. bit.ly/4ja0IY0
#RNAediting #leadership
ProQR Therapeutics (@proqr) 's Twitter Profile Photo

ProQR is officially a Great Place to Work! We’re proud to foster a culture where innovation, collaboration, and growth thrive—driven by our amazing team and our mission to develop transformative RNA therapies. bit.ly/42LdvZR #GPTW #Biotech #RNAEditing #Axiomer

ProQR Therapeutics (@proqr) 's Twitter Profile Photo

Today we announced our First Quarter Operating and Financial Results. Read the press release here: bit.ly/4dhMSRe $PRQR #RNAEditing #Axiomer

Today we announced our First Quarter Operating and Financial Results. 

Read the press release here: bit.ly/4dhMSRe 

$PRQR #RNAEditing #Axiomer
ProQR Therapeutics (@proqr) 's Twitter Profile Photo

Great catching up with @BiotechTVHQ at #ASGCT2025! Check out this clip featuring our CSO, Gerard Platenburg, as he shares how decades of expertise in oligonucleotides helps drive innovation in our Axiomer RNA editing platform and pipeline.

ProQR Therapeutics (@proqr) 's Twitter Profile Photo

From Amsterdam to New Orleans to San Diego – the month of May brought many connections with the field at #EASL, #ASGCT2025, and #TIDESUSA. Posters and presentations from ASGCT and TIDES are available on our website under Presentations and Publications. bit.ly/4kPCen7

From Amsterdam to New Orleans to San Diego – the month of May brought many connections with the field at #EASL, #ASGCT2025, and #TIDESUSA.

Posters and presentations from ASGCT and TIDES are available on our website under Presentations and Publications.

bit.ly/4kPCen7
ProQR Therapeutics (@proqr) 's Twitter Profile Photo

This week we held our biannual Axiomer Summit event – a day of vibrant discussions, insightful presentations, and an engaging poster session focused on our science. Thanks to our Scientific Advisory Board and Board members for joining this exciting exchange! #RNAEditing #Axiomer

This week we held our biannual Axiomer Summit event – a day of vibrant discussions, insightful presentations, and an engaging poster session focused on our science. Thanks to our Scientific Advisory Board and Board members for joining this exciting exchange!

#RNAEditing #Axiomer
ProQR Therapeutics (@proqr) 's Twitter Profile Photo

At ProQR, we’re proud to foster a culture where everyone feels safe to be themselves. To celebrate #Pride, our DEI team hosted a rainbow themed coffee & collaboration event with multicoloured cakes and a movie night featuring an LGBTQIA+ film and discussion. #RNAEditing #Axiomer

At ProQR, we’re proud to foster a culture where everyone feels safe to be themselves. To celebrate #Pride, our DEI team hosted a rainbow themed coffee & collaboration event with multicoloured cakes and a movie night featuring an LGBTQIA+ film and discussion.  #RNAEditing #Axiomer
ProQR Therapeutics (@proqr) 's Twitter Profile Photo

We are happy to announce the submission of a CTA to the EMA to initiate a Phase 1 clinical trial in healthy volunteers for AX-0810 targeting NTCP. Check out the press release for more details: bit.ly/4ljFzuQ #Axiomer #RNAEditing #BiotechNews

We are happy to announce the submission of a CTA to the EMA to initiate a Phase 1 clinical trial in healthy volunteers for AX-0810 targeting NTCP.

Check out the press release for more details: bit.ly/4ljFzuQ

#Axiomer #RNAEditing #BiotechNews
ProQR Therapeutics (@proqr) 's Twitter Profile Photo

As R&D Team Manager at ProQR, Lorenza drives scientific collaboration and project planning while also championing inclusivity as part of our DEI team. Meet the ProQR team at: bit.ly/4m4oZzs #Axiomer #RNAEditing #TeamProQR

As R&D Team Manager at ProQR, Lorenza drives scientific collaboration and project planning while also championing inclusivity as part of our DEI team.

Meet the ProQR team at: bit.ly/4m4oZzs

#Axiomer #RNAEditing #TeamProQR
ProQR Therapeutics (@proqr) 's Twitter Profile Photo

Great to connect with the local community at the Dutch Medicines Summer Afternoon! Our VP Axiomer Science, Lenka van Sint Fiet, demonstrated how #Axiomer is driving progress toward potentially transformative therapies. #RNAEditing #DutchBioScienceWeek

Great to connect with the local community at the Dutch Medicines Summer Afternoon! 

Our VP Axiomer Science, Lenka van Sint Fiet, demonstrated how #Axiomer is driving progress toward potentially transformative therapies.

#RNAEditing #DutchBioScienceWeek